A 17β‐derivative of allopregnanolone is a neurosteroid antagonist at a cerebellar subpopulation of GABAAreceptors with nanomolar affinity
Authors:
- 1 August 2007
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 151 (7) , 1078-1086
Abstract
Background and purpose: High‐affinity, subtype‐selective antagonists of the neurosteroid binding sites of GABAAreceptors are not available. We have characterized an allopregnanolone derivative as an antagonist of cerebellar GABAAreceptors with nanomolar affinity.Experimental approach: Receptor binding and electrophysiological methods were used for the allosteric modulation of cerebellar GABAAreceptors by an allopregnanolone derivative, (20R)‐17β‐(1‐hydroxy‐2,3‐butadienyl)‐5α‐androstane‐3α‐ol (HBAO). GABAAreceptors of rat cerebellar membranes were labelled with the chloride channel blocker [3H]ethynylbicycloorthobenzoate (EBOB). The ionophore function of GABAAreceptors was studied by whole‐cell patch clamp electrophysiology in cultured rat cerebellar granule and cortical cells.Key results: Partial displacement of cerebellar [3H]EBOB binding by nanomolar HBAO was attenuated by 0.1 mM furosemide, an antagonist of α6and β2‐3subunit‐containing GABAAreceptors. Displacement curves of HBAO were reshaped by 30 nM GABA and shifted to the right. However, the micromolar potency of full displacement by allopregnanolone was not affected by 0.1 mM furosemide or 30 nM GABA. The nanomolar, but not the micromolar phase of displacement of [3H]EBOB binding by GABA was attenuated by 100 nM HBAO. Submicromolar HBAO did not affect [3H]EBOB binding to cortical and hippocampal GABAAreceptors. HBAO up to 1 μM did not affect chloride currents elicited by 0.3‐10 μM GABA, while it abolished potentiation by 1 μM allopregnanolone with nanomolar potency in cerebellar but not in cortical cells. Furosemide attenuated cerebellar inhibition by 100 nM HBAO.Conclusions and implications: HBAO is a selective antagonist of allopregnanolone, a major endogenous positive modulator via neurosteroid sites of cerebellar (probably α6β2–3δ) GABAAreceptors.British Journal of Pharmacology(2007)151, 1078–1086; doi:10.1038/sj.bjp.0707316Keywords
This publication has 45 references indexed in Scilit:
- Neurosteroid Synthesis-Mediated Regulation of GABAAReceptors: Relevance to the Ovarian Cycle and StressThe Journal of Neuroscience, 2007
- Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesisProceedings of the National Academy of Sciences, 2006
- High affinity, heterogeneous displacement of [3H]EBOB binding to cerebellar GABAA receptors by neurosteroids and GABA agonistsNeuropharmacology, 2005
- Variations on an inhibitory theme: phasic and tonic activation of GABAA receptorsNature Reviews Neuroscience, 2005
- Selective Antagonism of 5α-Reduced Neurosteroid Effects at GABAA ReceptorsMolecular Pharmacology, 2004
- Subunit composition and quantitative importance of GABAAreceptor subtypes in the cerebellum of mouse and ratJournal of Neurochemistry, 2003
- Recent developments in structure–activity relationships for steroid modulators of GABAA receptorsBrain Research Reviews, 2001
- Characterisation of GABAA receptors in fetal, neonatal and adult ovine brain: region and age related changes and the effects of allopregnanoloneNeuropharmacology, 2000
- FROM KINETICS AND THERMODYNAMICS OF GABAA RECEPTOR BINDING TO IONOPHORE FUNCTIONNeurochemistry International, 1996
- The neuroactive steroid 3α-hydroxy-5β-pregnan-20-one is a two-component modulator of ligand binding to the GABAA receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1994